Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREATâ„¢ Registry.

Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Langholff W, Londhe A, Sandborn WJ. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREATâ„¢ Registry. Am J Gastroenterol. 2014 Feb; 109(2):212-23.

View in: PubMed

collapse authors with profiles